Yul Ri Chung

1.5k total citations
48 papers, 1.1k citations indexed

About

Yul Ri Chung is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Yul Ri Chung has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Yul Ri Chung's work include Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Cells and Metastasis (8 papers). Yul Ri Chung is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Cells and Metastasis (8 papers). Yul Ri Chung collaborates with scholars based in South Korea, Puerto Rico and Ethiopia. Yul Ri Chung's co-authors include So Yeon Park, Hyun Jeong Kim, Min Hye Jang, Jae Moon Gwak, Milim Kim, Eun Joo Kim, Han Suk Ryu, Ji Won Woo, Soomin Ahn and An Na Seo and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Yul Ri Chung

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yul Ri Chung South Korea	21	497	492	426	133	132	48	1.1k
Xianyu Zhang China	17	307 0.6×	295 0.6×	649 1.5×	113 0.8×	143 1.1×	52	1.0k
Esther M. de Kruijf Netherlands	18	363 0.7×	724 1.5×	614 1.4×	123 0.9×	114 0.9×	23	1.5k
Sasagu Kurozumi Japan	21	536 1.1×	584 1.2×	513 1.2×	164 1.2×	94 0.7×	63	1.2k
Zahra Mohammed United Kingdom	12	208 0.4×	283 0.6×	243 0.6×	70 0.5×	73 0.6×	18	619
Yoshiya Horimoto Japan	20	378 0.8×	694 1.4×	495 1.2×	235 1.8×	154 1.2×	97	1.2k
Francesco Merolla Italy	25	209 0.4×	486 1.0×	845 2.0×	247 1.9×	87 0.7×	66	1.3k
Jianbo He United States	17	224 0.5×	301 0.6×	487 1.1×	102 0.8×	50 0.4×	49	1.1k
Thomas B. Karasic United States	16	282 0.6×	711 1.4×	486 1.1×	279 2.1×	94 0.7×	65	1.3k
Lydia Gaba Spain	13	487 1.0×	786 1.6×	516 1.2×	364 2.7×	88 0.7×	47	1.4k
Vanesa Valero Spain	10	185 0.4×	508 1.0×	1.0k 2.4×	223 1.7×	141 1.1×	12	1.3k

Countries citing papers authored by Yul Ri Chung

Since Specialization

Citations

This map shows the geographic impact of Yul Ri Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yul Ri Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yul Ri Chung more than expected).

Fields of papers citing papers by Yul Ri Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yul Ri Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yul Ri Chung. The network helps show where Yul Ri Chung may publish in the future.

Co-authorship network of co-authors of Yul Ri Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Yul Ri Chung. A scholar is included among the top collaborators of Yul Ri Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yul Ri Chung. Yul Ri Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Woo, Ji Won, Hyun Jung Kwon, Yul Ri Chung, et al.. (2024). Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status. Laboratory Investigation. 104(8). 102092–102092. 1 indexed citations

Chung, Yul Ri, et al.. (2022). Comparative analysis of high- and low-level deep learning approaches in microsatellite instability prediction. Scientific Reports. 12(1). 12218–12218. 4 indexed citations

Chung, Yul Ri, Ji Won Woo, Soomin Ahn, et al.. (2021). Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Scientific Reports. 11(1). 12128–12128. 3 indexed citations

Jang, Bo Gun, Hyunho Park, Baek‐hui Kim, et al.. (2020). A Prospective Validation and Observer Performance Study of a Deep Learning Algorithm for Pathologic Diagnosis of Gastric Tumors in Endoscopic Biopsies. Clinical Cancer Research. 27(3). 719–728. 31 indexed citations

Kim, Milim, Yul Ri Chung, Hyun Jeong Kim, et al.. (2020). Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Research. 22(1). 32–32. 36 indexed citations

Woo, Ji Won, Yul Ri Chung, Soomin Ahn, et al.. (2019). Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value. Journal of Breast Cancer. 22(3). 439–439. 21 indexed citations

Chung, Yul Ri, Kees-Peter de Roos, Marcel W. Bekkenk, et al.. (2019). Poor agreement between the automated risk assessment of a smartphone application for skin cancer detection and the rating by dermatologists. Journal of the European Academy of Dermatology and Venereology. 34(2). 274–278. 10 indexed citations

Chang, Won, Jae Young Lee, Jae Hwan Lee, et al.. (2017). A portable high-intensity focused ultrasound system for the pancreas with 3D electronic steering: a preclinical study in a swine model. ULTRASONOGRAPHY. 37(4). 298–306. 6 indexed citations

Jang, Min Hye, Hyun Jeong Kim, Jae Moon Gwak, Yul Ri Chung, & So Yeon Park. (2017). Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer. Human Pathology. 68. 69–78. 59 indexed citations

10.

Jang, Min Hye, et al.. (2017). A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method. PLoS ONE. 12(2). e0172031–e0172031. 38 indexed citations

11.

Jang, Min Hye, Yul Ri Chung, Eunyoung Kang, et al.. (2016). Prognostic significance of centromere 17 copy number gain in breast cancer depends on breast cancer subtype. Human Pathology. 61. 111–120. 10 indexed citations

12.

Jang, Min Hye, Eun Joo Kim, Hyun Jeong Kim, Yul Ri Chung, & So Yeon Park. (2015). Assessment of HER2 status in invasive breast cancers with increased centromere 17 copy number. Breast Cancer Research and Treatment. 153(1). 67–77. 21 indexed citations

13.

Jang, Min Hye, Hyun Jeong Kim, Eun Joo Kim, Yul Ri Chung, & So Yeon Park. (2015). Expression of epithelial-mesenchymal transition–related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome. Human Pathology. 46(9). 1267–1274. 117 indexed citations

14.

Jin, Min‐Sun, Chang Lim Hyun, In Ae Park, et al.. (2015). SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer. Tumor Biology. 37(4). 4743–4753. 34 indexed citations

15.

Chung, Yul Ri, Jae‐Kyung Won, Kyung Chul Moon, et al.. (2015). Cytomorphological characteristics of low‐grade papillary urothelial carcinoma for differential diagnosis from benign papillary urothelial lesions: logistic regression analysis in SurePath^™ liquid‐based voided urine cytology. Cytopathology. 27(2). 83–90. 6 indexed citations

16.

Kim, Hyojin, Kyung-Hun Lee, In Ae Park, et al.. (2015). Expression of SIRT1 and apoptosis-related proteins is predictive for lymph node metastasis and disease-free survival in luminal A breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 467(5). 563–570. 11 indexed citations

17.

Chung, Soo Young, Yoon Yang Jung, In Ae Park, et al.. (2015). Oncogenic role of SIRT1 associated with tumor invasion, lymph node metastasis, and poor disease-free survival in triple negative breast cancer. Clinical & Experimental Metastasis. 33(2). 179–185. 25 indexed citations

18.

Ryu, Han Suk, Young Soo Park, Hyo Jin Park, et al.. (2014). Expression of Indoleamine 2,3-Dioxygenase and Infiltration of FOXP3+ Regulatory T Cells Are Associated with Aggressive Features of Papillary Thyroid Microcarcinoma. Thyroid. 24(8). 1232–1240. 24 indexed citations

19.

Park, In Ae, Yul Ri Chung, Hyojin Kim, et al.. (2014). A histomorphologic predictive model for axillary lymph node metastasis in preoperative breast cancer core needle biopsy according to intrinsic subtypes. Human Pathology. 46(2). 246–254. 10 indexed citations

20.

Chung, H., Jong-Mo Seo, Yul Ri Chung, et al.. (2003). In vivo Biocompatibility and Stability of Polyimide Microelectrode Array for Retinal Stimulation. Investigative Ophthalmology & Visual Science. 44(13). 5072–5072. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact